Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration

Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi
  • Journal of Market Access & Health Policy, January 2018, Taylor & Francis
  • DOI: 10.1080/20016689.2018.1433426
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: